The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy.
D'adda
Mariella
M
Micheletti
Moira
M
Drera
Monica
M
Ferrari
Samantha
S
Rossi
Giuseppe
G
D000328:Adult; D000368:Aged; D001792:Blood Platelets; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D005260:Female; D006454:Hemoglobins; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D012189:Retrospective Studies; D013922:Thrombocytosis / Q000188:drug therapy*
D006454:Hemoglobins; D011799:Quinazolines; C021139:anagrelide; D006918:Hydroxyurea